Literature DB >> 2278965

Uterine leiomyoma cytogenetics.

M Nibert1, S Heim.   

Abstract

Uterine leiomyoma--a benign smooth muscle tumor--has recently been found to contain tumor-specific chromosome aberrations. Although only normal karyotypes were detected in 50 to 80% of cytogenetically investigated tumors, 104 leiomyomas with karyotypic aberrations have already been reported. At least four cytogenetically abnormal subgroups have been identified thus far, characterized by rearrangements of 6p, del(7)(q21.2q31.2), +12, and t(12;14)(q14-15;q23-24). The remaining abnormal tumors have had various nonrecurrent anomalies. Secondary karyotypic rearrangements, sometimes including ring chromosomes, have been found in one-third and reflect clonal evolution. Occasional leiomyomas have contained multiple numerical and structural rearrangements. Though benign, these cytogenetically grossly aberrant tumors often displayed more atypical histological features than are usually seen in leiomyoma. Multiple leiomyomas have been investigated from 69 patients, with detection of chromosome anomalies in at least two separate tumors from the same uterus in ten cases. In half of these patients unrelated aberrations were found in different leiomyomas from the same uterus. On other occasions the aberrations were identical, indicating that although some uterine leiomyomas originate independently, others may develop by intra-myometrial spreading from a common neoplastic clone. Some common features are discernible between the karyotypic pictures of uterine leiomyoma and angioleiomyoma; rearrangements of 6p, 13q, and 21q have been described in both tumor types. The cytogenetic similarities so far detected between leiomyoma and the malignant muscle tumors--leiomyosarcoma and rhabdomyosarcoma--are few and may be fortuitous. The cytogenetic profiles of leiomyoma and lipoma are strikingly similar; both tumor types have nonrandom rearrangements of 12q13-15, t(12;14) in leiomyoma and t(3;12) in lipoma, as well as variant rearrangements of the same 12q segment. Both also have cytogenetic subgroups characterized by changes in 6p and ring chromosomes. Finally, karyotypic similarities exists also between leiomyoma and pleomorphic adenoma of the salivary gland, which includes a subset of tumors with anomalies of 12q13-15, and with myxoid liposarcoma, which has t(12;16)(q13;p11) as a tumor-specific rearrangement.

Entities:  

Mesh:

Year:  1990        PMID: 2278965     DOI: 10.1002/gcc.2870020103

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  30 in total

1.  Immortalization of primary human smooth muscle cells.

Authors:  N Perez-Reyes; C L Halbert; P P Smith; E P Benditt; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

2.  Disseminated peritoneal leiomyomatosis after laparoscopic supracervical hysterectomy with characteristic molecular cytogenetic findings of uterine leiomyoma.

Authors:  Zehra Ordulu; Paola Dal Cin; Wilson W S Chong; Kwong Wai Choy; Charles Lee; Michael G Muto; Bradley J Quade; Cynthia C Morton
Journal:  Genes Chromosomes Cancer       Date:  2010-12       Impact factor: 5.006

Review 3.  Warner-Lambert/Parke-Davis Award lecture. Many tumors and many genes: genetics of uterine leiomyomata.

Authors:  C C Morton
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

4.  Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.

Authors:  Jennelle C Hodge; Tae-Min Kim; Jonathan M Dreyfuss; Priya Somasundaram; Nicole C Christacos; Marissa Rousselle; Bradley J Quade; Peter J Park; Elizabeth A Stewart; Cynthia C Morton
Journal:  Hum Mol Genet       Date:  2012-02-17       Impact factor: 6.150

Review 5.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

6.  Identifying the molecular signature of the interstitial deletion 7q subgroup of uterine leiomyomata using a paired analysis.

Authors:  Jennelle C Hodge; Peter J Park; Jonathan M Dreyfuss; Iman Assil-Kishawi; Priya Somasundaram; Luwam G Semere; Bradley J Quade; Allison M Lynch; Elizabeth A Stewart; Cynthia C Morton
Journal:  Genes Chromosomes Cancer       Date:  2009-10       Impact factor: 5.006

Review 7.  Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms.

Authors:  C Sreekantaiah; M Ladanyi; E Rodriguez; R S Chaganti
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

8.  Chromosome aberrations and cytogenetic intratumor heterogeneity in chondrosarcomas.

Authors:  C Orndal; N Mandahl; A Rydholm; H Willén; O Brosjö; F Mitelman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway.

Authors:  Binny V Varghese; Faezeh Koohestani; Michelle McWilliams; Arlene Colvin; Sumedha Gunewardena; William H Kinsey; Romana A Nowak; Warren B Nothnick; Vargheese M Chennathukuzhi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-02       Impact factor: 11.205

10.  Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids.

Authors:  William H Catherino; Phyllis C Leppert; Matthew H Stenmark; Mark Payson; Clariss Potlog-Nahari; Lynnette K Nieman; James H Segars
Journal:  Genes Chromosomes Cancer       Date:  2004-07       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.